Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Mallinckrodt Plc (MNK)

Mallinckrodt Plc (MNK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,481
  • Shares Outstanding, K 13,171
  • Annual Sales, $ 1,914 M
  • Annual Income, $ -911,200 K
  • EBIT $ -421 M
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales 0.00
  • Price/Cash Flow N/A
  • Price/Book 0.01
  • Price/Earnings ttm 0.04
  • Earnings Per Share ttm 9.55
  • Most Recent Earnings $-1.45 on 08/09/23
  • Next Earnings Date 08/08/23
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Sell
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 1.38
  • Number of Estimates 7
  • High Estimate 1.61
  • Low Estimate 1.17
  • Prior Year 2.07
  • Growth Rate Est. (year over year) -33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3000 +16.83%
on 08/25/23
2.0400 -82.82%
on 08/08/23
-0.7295 (-67.55%)
since 07/28/23
3-Month
0.3000 +16.83%
on 08/25/23
3.1100 -88.73%
on 05/30/23
-2.6495 (-88.32%)
since 05/26/23
52-Week
0.3000 +16.83%
on 08/25/23
18.1000 -98.06%
on 10/27/22
-10.9995 (-96.91%)
since 08/17/22

Most Recent Stories

More News
Keenova to Participate in the Jefferies Global Healthcare Conference in London

DUBLIN , Nov. 12, 2025 /PRNewswire/ -- Keenova Therapeutics plc ("Keenova" or the "Company") today announced that management will present at the Jefferies Global Healthcare Conference in London...

MNK : 0.3402 (-14.97%)
Mallinckrodt Reports Third Quarter 2025 Financial Results

Delivers Third Quarter Net Sales of $753.1 Million, Driven by Acthar ® Gel (repository corticotropin injection) Growth and the Inclusion of Two Months of Endo Product Net Sales

MNK : 0.3402 (-14.97%)
Mallinckrodt Completes Spin-Off of Par Health, Introduces Keenova Therapeutics

Keenova Focused on Advancing Therapies to Address Unmet Patient Needs 

MNK : 0.3402 (-14.97%)
Mallinckrodt to Present Data on Terlipressin at the 2025 American Association for the Study of Liver Diseases (AASLD) Annual Meeting

– Four poster presentations, including one AASLD Poster of Distinction, will highlight research in hepatorenal syndrome –

MNK : 0.3402 (-14.97%)
Mallinckrodt plc to Report Third Quarter 2025 Financial Results on November 10, 2025

DUBLIN , Oct. 23, 2025 /PRNewswire/ -- Mallinckrodt plc , a global specialty pharmaceutical company, announced today that it will report its third quarter 2025 financial results on Monday, November...

MNK : 0.3402 (-14.97%)
Mallinckrodt Recognizes First Hepatorenal Syndrome (HRS) Awareness Day

– HRS Awareness Day will be observed annually on October 14 during National Liver Awareness Month, with the goal of raising awareness around a life-threatening condition that occurs in people with advanced...

MNK : 0.3402 (-14.97%)
Mallinckrodt Announces Publication of Findings on Treatment Patterns and Outcomes in Patients with Two Types of Arthritis Treated with Acthar® Gel (repository corticotropin injection)

– Cross-sectional physician survey and medical chart review showed some patients evaluated with AS or PsA who were treated with Acthar Gel experienced a reported reduction in overall symptoms, decreased...

MNK : 0.3402 (-14.97%)
Mallinckrodt Names Christiana Stamoulis as President and Chief Financial Officer

DUBLIN , Aug. 6, 2025 /PRNewswire/ -- Mallinckrodt plc today announced the appointment of Christiana Stamoulis as President and Chief Financial Officer, effective September 22,...

MNK : 0.3402 (-14.97%)
Mallinckrodt plc Reports Financial Results for Second Quarter 2025 and Provides Guidance

Legacy Mallinckrodt Second Quarter 2025 Results

MNK : 0.3402 (-14.97%)
Mallinckrodt Names Leslie Donato to Board of Directors

Appointment of Former Cencora Executive Completes Nine-Member Board

MNK : 0.3402 (-14.97%)

Business Summary

Mallinckrodt Plc. develops, produces, markets and distributes specialty pharmaceutical products and therapies. The company offers branded pharmaceutical products for autoimmune and rare diseases in specialty areas such as rheumatology, nephrology, neurology, pulmonology and ophthalmology. It also offers...

See More

Key Turning Points

3rd Resistance Point 0.5105
2nd Resistance Point 0.4603
1st Resistance Point 0.4003
Last Price 0.3402
1st Support Level 0.2901
2nd Support Level 0.2399
3rd Support Level 0.1799

See More

52-Week High 18.1000
Fibonacci 61.8% 11.3004
Fibonacci 50% 9.2000
Fibonacci 38.2% 7.0996
Last Price 0.3402
52-Week Low 0.3000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar